Market Segmentation

• End User (Hospitals and Clinics, Nursing Homes, Elderly Care Centers, and Home-Use)

Regional Segmentation

• North America – U.S., Canada
• EU5 – Germany, France, Italy, U.K., Spain
• Asia-Pacific – China, Japan, India, South Korea, Rest-of-Asia-Pacific (RoAPAC)
• Rest-of-the-World

Growth Drivers

• Rising Number of Startups Driving Innovation
• Increasing Prevalence of Obstructive Sleep Apnea
• Growing Prevalence of Respiratory Diseases Among the Geriatric Population
• Growing Prevalence of Chronic Respiratory Diseases across the Globe

Market Challenges

• High Upfront Cost of Device
• Side-Effects Associated with Long-Term Usage

Market Opportunities

• Development of Smart CPAP Devices
• Digitization of Device Training Modules to Promote Adoption

Key Companies Profiled

Airon Corporation, APEX MEDICAL CORP., Asahi Kasei Corporation, BMC Medical Co., Ltd, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, General Electric Company, Getinge AB, Koninklijke Philips N.V., Löwenstein Medical GmbH & Co. KG, Medical Depot, Inc. dba drives DeVilbiss Healthcare LLC, Medtronic Plc, ResMed, Inc., Smiths Group plc (Smiths Medical) and VYAIRE MEDICAL, INC.

Key Questions Answered in this Report:

• How has COVID-19 impacted the adoption of CPAP devices in the market?
• What are the key regulations which influence the adoption of CPAP devices in the market?
• What are some of the key brands in the global and regional CPAP market?
• Who are the top competitors in each region?
• What are some of the key factors influencing the growth in adopting CPAP devices across the globe?
• How do the brands compare against each other in terms of unit shipments?
• What are the fastest-growing countries in terms of CPAP adoption?
• Which are the key diseases driving the adoption of CPAP devices across the world?
• What are the key strategies being adopted by market players in the global CPAP market?
• Who are the most common end-users of CPAP devices, and how are the end-use segment expected to grow in the future?

Key USPs of the Report

Following are some of the key contents of the report:

• Epidemiological Landscape
This section includes exhaustive information on the epidemiology of key disease indications for the CPAP domain.

• Patent Scenario
This section encompasses a description of the current patent landscape in the continuous positive airway pressure field.

• Regulatory Framework
This section comprises the information on the regulatory framework for various regulatory bodies associated with granting approval to CPAP devices.

• Impact of COVID-19
This section of the report encompasses the following:
o Impact on CPAP Demand and Supply
o Regional Impact
o Future Impact (Short-, mid-, and long-term)

In addition, the report provides:

• A detailed analysis and growth forecast (2020-2026) for different end-users
• Recent developments and trends in the global market landscape
• Factors promoting and inhibiting the market growth

Expert Quote

“At present, what we have is heavy demand for CPAP devices due to the emergency regulatory authorizations made by FDA to use CPAP devices during the treatment of COVID-19. Will this demand remain high in the future when the healthcare industry is normalizing? It remains to be seen. The general idea is that it will gradually reduce back to normal, the rate of which depends on the type of recovery pattern from COVID-19”.

Scope of the Global CPAP Market

The purpose of the study is to enable the reader to gain a holistic view of the global CPAP market by each of the aforementioned segments.

The report constitutes an in-depth analysis of the global CPAP market, including a thorough analysis of the different end-users. The study also provides exhaustive information on disease epidemiology, competitive landscape, brand share landscape, market share of the leading players, number of CPAP units shipped, as well as other vital information with respect to the global CPAP market. The report considers CPAP device and Ventilators (offering CPAP mode) manufacturers.

The post Global Continuous Positive Airway Pressure (CPAP) Market: Analysis and Forecast, 2020-2026 first appeared on CRI Report.

Market Segmentation

• Product Type (Integrated and Standalone)
• CDSS Type (Conventional and Advanced)
• Application (Preventive Care, Diagnostics, Follow-Up Management, Others (Planning, Implementation, etc.)
• End User (Hospitals and Clinics, Ambulatory Surgical Centers, Other End Users (Nursing Homes, Elderly Care Centers, etc.)
• User Interactivity (Active CDSS and Passive CDSS)
• Model (Knowledge-Based and Non-Knowledge Based)
• Delivery Mode (On-Premise CDSS and Cloud-Based CDSS)

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, Italy, U.K., Spain, Rest-of-Europe
• Asia-Pacific – China, Japan, India, Australia, South Korea, Rest-of-Asia-Pacific (RoAPAC)
• Rest-of-the-World

Growth Drivers

• Growing Emphasis on Reducing Medical Errors and Hospital Readmission Rates to Reduce Healthcare Costs
• Rise in the Number of Chronic Diseases
• Technological Advancements in the Field of Information Technology
• Shortage of Healthcare Workforce to Drive Demand for CDSS
• Partnerships between CDSS Vendors and Cloud-Based Service Providers

Market Challenges

• Reluctance of Clinicians to use CDSS Systems due to Computer Illiteracy
• Lack of Interoperability among CDSS and EHR
• Data Security and Privacy Concerns

Market Opportunities

• Integration of CDSS with Blockchain
• Collaborations with Precision Medicine Providers
• Business Expansion in the Emerging Markets
• Product Differentiation

Key Companies Profiled

Allscripts Healthcare Solutions, Inc., Cerner Corporation, Change Healthcare, General Electric Company, International Business Machines Corporation, McKesson Corporation, RELX Group, Wolters Kluwer N.V., Epic Systems Corporation, Hearst Corporation, Inferscience, Inc., Medical Information Technology, Inc. (MEDITECH), Oncology Analytics, Inc., Persivia Inc., and VisualDx. In addition, the report also provides snapshots for three players, namely, CureMD Healthcare, RAMPmedical Henisaja GmbH, and The Medical Algorithms Company Limited.

Key Questions Answered in this Report:

• How has COVID-19 impacted the adoption of CDSS as well as the market dynamics influencing it?
• What are the key regulations governing the CDSS market in key regions?
• What are the technological developments which are expected to have the maximum influence on the global CDSS market?
• Who are the leading players to hold significant dominance on the global CDSS market currently?
• What are the key business models being followed by the key players in the market?
• What are some of the major factors which are expected to influence the growth in adoption of CDSS across the globe?
• What are the key strategies incorporated by leading players in the global CDSS market landscape?
• What is the current revenue contribution for the different types of CDSS, and what are the expected modifications in the forecast period?
• Which countries contribute to the major share of the current demand, and which ones hold significant scope for growth during the next 10 years?

Key USPs of the Report

Following are some of the key contents of the report:

• Industry Analysis
o Ecosystem Analysis
o Evidence-Based Analysis
o Entry Barriers to Adoption/Implementation
o Regulatory Framework
o Patent Landscape

• Impact of COVID-19
This section of the report encompasses the following:
o Key Trends
o Scenario Competitive Analysis (Pre-COVID, During-COVID, and Post-COVID-19)
o Effect on Competitive Landscape and Product Demand
o Regional Impact
o Future Perspective and Recommendations

In addition, the report provides:

• A detailed analysis and growth forecast (2021-2030) for different market segments
• Recent developments and trends in the global market landscape
• Factors promoting and inhibiting the market growth
• Company revenue share analysis for 2019

Expert Quote

“The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes.”

Scope of the Global CDSS Market

The purpose of the study is to enable the reader to gain a holistic view of the global CDSS market by each of the segments mentioned above.

The research report constitutes an in-depth study of the global CDSS market, including a thorough analysis of revenues generated from the use of CDSS in professional healthcare settings. Based on the product launches, approvals, and ongoing strategic collaborations, as well as business expansions, the market size and potential for the forecast period of 2021-2030 have been estimated.

The post Global Clinical Decision Support Systems (CDSS) Market: Analysis and Forecast, 2021-2030 first appeared on CRI Report.

• What are the major drivers, challenges, and opportunities for the urban air mobility market during the forecast period 2023-2035?
• What is the expected revenue generated by the global urban air mobility market during the forecast period 2023-2035?
• What are the recent trends in the end-use application segment?
• Who are the key players in the urban air mobility market, and what is their competitive benchmarking?
• What are the strategies adopted by the key players in the market to increase its market share in the industry?
• Which applications of the aerial vehicles and drones are expected to dominate the market in 2035?
• What are the competitive strengths of the key players in the urban air mobility market?
• What would be the aggravated revenue generated by the urban air mobility market segmented by region (North America, Europe, Asia-Pacific, and Rest-of-the-World) by 2035?

Global Urban Air Mobility Market Forecast, 2023-2035

The urban air mobility industry analysis by BIS Research projects the market to have a significant growth of CAGR 27.37% based on the values during the forecast period from 2023 to 2035. The Asia-Pacific region is expected to dominate the market by 2035 with a share of 39.27%. The Asia-Pacific region includes China, Japan, South Korea, and Singapore, but China is expected to acquire a major share in 2035 due to the increase in the population and traffic congestion in megacities in the country.

The urban air mobility market has gained huge importance in the past few years. This is due to the rising demand for an alternate mode of transportation that is quicker and more efficient than the current transportation services. Several government agencies and associations have started drafting policies and regulations to make sure that the airspace is managed to enable higher and safer operations of the aircraft and drones.

Scope of the Global Urban Air Mobility Market

The global urban air mobility market research provides the market information for segmentation, such as the classification of the vehicles based on their range and application, as well as the ecosystem, operations, end-use industry, and platform architecture. The market analysis examines the urban air mobility market outlook in terms of the trends, driving forces, opportunities, technological advancements, and competitive benchmarking, among others.

The report further takes into consideration the market and business dynamics, along with the detailed product contribution of the key players operating in the market.

Global Urban Air Mobility Market Segmentation

The report constitutes an extensive study of the urban air mobility industry. The report largely focuses on providing market information for the air mobility vehicles covering various segments, products, applications, and regions. The travel range included less than 20 kilometers, 20 – 100 kilometers, 100-400 kilometers, and greater than 400 kilometers. The applications were classified into passenger transportation, cargo transportation, medical and emergency aid transportation, and food delivery. The market is further segmented into operation, end-use industry, and platform architecture such as fixed-wing, rotor-wing, and others.

The urban air mobility market is segregated by region under four major regions, namely North America, Europe, APAC, and Rest-of-the-World. Data for each of these regions (by country) is provided.

Key Companies in the Global Urban Air Mobility Industry

The key players in the global urban air mobility market include Acubed by Airbus S.A.S.(U.S.), Airspace Experience Technologies (U.S.), Aurora Flight Sciences (U.S.), Bell Textron Inc (U.S.), DELOREAN AEROSPACE (U.S.), EHang (China), EVE Air Mobility (U.S.), Joby Aviation (U.S.), Kitty Hawk (U.S.), Lilium GmbH (Germany), NEVA Aerospace (U.K.), Opener (U.S.), Pipistrel Group (Slovenia), Volocopter GmbH (Germany), and other key players.

The post Urban Air Mobility (UAM) Market – A Global and Regional Analysis: Focus on Range, Application, Ecosystem, Operation, End-User, Platform Architecture, and Country – Analysis and Forecast, 2023-2035 first appeared on CRI Report.

Market Segmentation

• Product – Services and Products (Kits and Assays, Instruments, Reagents, and Software)
• Process – Starting Material Preparation, Upstream Processing, and Downstream Processing
• Analytical Methods – Safety Testing, Purity Testing, Potency Testing, Identity Testing, and Stability Testing
• Technology – Polymerase Chain Reaction (PCR), Flow Cytometry, Limulus Amebocyte Lysate (LAL), Enzyme-Linked Immunosorbent Assay (ELISA), Chromatography, Mass Spectrometry, Western Blotting, Next-Generation Sequencing (NGS), and Electrophoresis, among others

Regional Segmentation

• North America – U.S., and Canada
• Europe – Germany, U.K., France, Italy, Spain, Netherlands, Russia, and Rest-of-Europe
• Asia-Pacific – China, Japan, India, Australia, South Korea, Singapore, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World

Growth Drivers

• Increasing Prevalence of Cancer and Chronic Diseases
• Rising Number of Clinical Trials
• Steady Investment and Consolidation in the Cell and Gene Therapy Market
• Favorable Regulatory Environment

Market Challenges

• Lack of Reliable Vector Production for Cell and Gene Therapy
• Lack of Therapy Specific Assays

Market Opportunities

• Drug Approvals and Strong Pipeline of Cell and Gene Therapies
• Multiple Investments in Expansion of cGMP Units

Key Companies Profiled

bioMérieux SA, Bio-Techne Corporation, Catalent, Inc., Charles River Laboratories International, Inc., Eurofins Scientific S.E., F. Hoffmann-La Roche Ltd., Intertek Group plc, Lonza Group AG, Merck KGaA, Sartorius AG, SGS S.A, Thermo Fisher Scientific Inc., WuXi AppTec, Sistemic Scotland Limited, and Vigene Biosciences, Inc.

Key Questions Answered in this Report:

• What are the major market drivers, challenges, and opportunities and their respective impacts in the global cell and gene therapy manufacturing QC market?
• What is the potential impact of advancement in QC in the contract development and manufacturing organization among the cell and gene therapy innovators?
• What is the current market demand along with future expected demand for the global cell and gene therapy manufacturing QC market?
• What are the key regulatory hurdles for industry players looking to enter this highly dynamic market?
• What are the key development strategies that are implemented by the major players in order to sustain the competitive market?
• How is each of the following segments of the market expected to grow during the forecast period from 2020 to 2030:
o product
o process
o analytical method
o technology
o region, namely, North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World (RoW)
• Who are the leading players with significant offerings to the global cell and gene therapy manufacturing QC market? What is the expected market dominance for each of these leading players?
• Which emerging companies are anticipated to be highly disruptive in the future, and what are their key strategies for sustainable growth in the global cell and gene therapy manufacturing QC market?
• How is automation expected to change scale up challenges in the market?
• What is the cost of QC vs production cost for cell and gene therapies and what strategies are leading players undertaking in order to maximize profits?

Market Overview

Our healthcare experts have found the manufacturing QC for cell and gene therapy to be one of the most rapidly evolving and dynamic markets and the global market for cell and gene therapy manufacturing QC is predicted to grow at a CAGR of 22.80% over the forecast period of 2020-2030. The market is driven by certain factors, which include increasing prevalence of cancer and chronic diseases, rising number of clinical trials for cell and gene therapy, steady investment and consolidation in the cell and gene therapy market, and favorable regulatory environment are fueling the growth of the global cell and gene therapy manufacturing QC market.

Manufacturing, being a hallmark of enabling advanced therapies to be disseminated across the patient population, is a consistent driving force behind the growth of overall adoption of innovative therapies. Quality control is a critical aspect of manufacturing, particularly considering advanced therapies such as cell and gene therapies. Profit generation aside, the cost of therapied can primarily be controlled through optimizing manufacturing costs. This will also require the optimization of cost in the underlying factors, including quality control. While a majority of regulators are currently mandating rapid testing technologies, CDMO juggernauts have already begun offering services and products based on advanced technologies such as NGS and PCR. Not only as an attractive promoting tool to gather more cell and gene innovators, but these market leaders are also driving consolidation within the industry by acquiring smaller companies offering unique products and services. As a result, there is tremendous dynamicity in the market, propelling overall access to cell and gene therapies even in smaller developing countries.

Within the research report, the market is segmented on the basis of products, processes, analytical methods, technologies, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

Rapid technological developments and their simultaneous adoption among major companies have made the global cell and gene therapy manufacturing QC market one of the most lucrative opportunities for major companies within the precision therapeutics biosphere. With both market juggernauts and emerging companies playing a significant role in the market, this industry is rapidly evolving into a highly rewarding market for manufacturers and end users. Although mostly based in Europe, market leaders such as Merck KGaA and Lonza Group AG, have been at the forefront in enabling cell and gene manufacturing capabilities across North America and the Asia-Pacific regions.

On the basis of region, North America holds the largest share of the cell and gene therapy manufacturing QC market due to a high number of active cell and gene therapy clinical trials, massive government funding, expansion activities by major companies, and an overall high adoption rate for advancing therapies. Apart from this, Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period, 2020-2030.

The post Global Cell and Gene Therapy Manufacturing QC Market: Focus on Products and Services, Process, Analytical Method, Technology, 17 Countries’ Data and Competitive Landscape – Analysis and Forecast, 2020-2030 first appeared on CRI Report.

Market Segmentation

• Product Type – Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS)[Endoscopes and Endoscopy Systems, Videoscopes, Endoscopic Ultrasound, Therapeutic Energy Devices], Surgical Robotics (Robotic Systems, Robotic Surgery Instruments and Accessories, Services)
• Surgery – Adrenalectomy, Appendectomy, Bariatric Surgery, Cholecystectomy, Colon and Rectal Surgery, Foregut Surgery, Hernia Repair
• End User – Conventional Technologies (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), Surgical Robotics (Hospitals, Ambulatory Surgical Centers, Specialty Clinics)

Regional Segmentation

• North America: U.S. and Canada
• Europe: Germany, U.K, Italy, Spain, France, and Rest-of-Europe
• Asia-Pacific: Japan, China, India, South Korea, Australia and New Zealand, and Rest-of-Asia-Pacific
• Rest-of-the-World

Growth Drivers

• Advantages of Minimally Invasive Surgical Procedures Over Conventional Open Surgical Procedures
• Availability of Technological Advanced Products in the Field of GI Surgical Procedures
• Increasing Healthcare Spending
• Growth in Robotics GI Surgical Procedures

Market Challenges

• High Cost of Minimally Invasive GI Surgical Procedures
• Shortage of Skilled Professionals
• Restrictive Reimbursement Framework

Market Opportunities

• Development of Long-Distance Teleoperated Surgical Robotic Systems
• Mergers and Acquisitions to Diversify Endoscopic Portfolio
• Investment for Regional Expansionts

Key Companies Profiled

Ambu A/S, B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cook Medical Inc., Intuitive Surgical, Inc., Olympus Corporation, Medtronic plc, Karl Storz SE & Co. KG, Stryker Corporation, Schölly Fiberoptic GmbH, Xenocor Inc., Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Richard Wolf GmbH, and TransEnterix, Inc.

Key Questions Answered in this Report:

• What is the current market size and future potential of these products?
• What is the current market share and growth share of the different products in the market?
• What are the guidelines implemented by different government bodies to regulate the approval of minimally invasive gastrointestinal surgical systems?
• What are the major market drivers, restraints, and opportunities in the global minimally invasive gastrointestinal surgical systems market?
• What is the impact of the COVID-19 pandemic on the market?
• Which technology is being researched and worked upon to improve the gastrointestinal surgical systems?
• Who are the leading players dominating the global minimally invasive gastrointestinal surgical systems market?
• What are the key development and strategies incorporated by the players of global minimally invasive gastrointestinal surgical systems market, to sustain the competition and retain their supremacy?
• Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global minimally invasive gastrointestinal surgical systems market?
• How advanced technologies such as surgical robotics is gaining traction in terms of market share in in gastrointestinal space?

Overview on the Global Minimally Invasive Gastrointestinal Surgical Systems Market

The global minimally invasive gastrointestinal surgical systems market is currently witnessing a significant change in the market landscape. There is rising investment in the development of healthcare infrastructure, increasing evidence for efficient and promising results in surgery assistance. Thus, this is leading to potential growth opportunities for the minimally invasive gastrointestinal surgical systems market. Moreover, there is an extensive entry of emerging players developing MIS surgical systems. All these predominant factors have led to a significant rise in sales of minimally invasive gastrointestinal surgical systems across the globe.

Global Minimally Invasive Gastrointestinal Surgical Systems Market (2020-2031)

The global minimally invasive gastrointestinal surgical systems market was valued at $5,021.8 million in 2020 and is anticipated to reach $10,441.0 million by 2031, growing at a CAGR of 6.8% during the forecast period 2021-2031. The increasing complexities in clinical decision-making, rising radiologist workload, and huge R&D investments are the major factors fueling the market growth. In addition to these factors, there are significant challenges and restraints, which are restricting the market growth. These challenges include the shortage of skilled professionals, high cost of minimally invasive GI surgical procedures, and restrictive reimbursement framework. Hence, it is anticipated that these trends will have a significant impact on the minimally invasive gastrointestinal surgical systems market in the during the forecast period, and the market will grow multifold.

Competitive Landscape

The global minimally invasive gastrointestinal surgical systems market consists of numerous large-scale as well as small-scale manufacturers and vendors. Presently, with the increasing adoption of technologies in healthcare, the manufacturers in the market have an ample number of opportunities to expand their offerings and to establish a strong foothold in the market.

From January 2015 to January 2021, the market witnessed approximately 25 regulatory and legal developments, 11 new offerings, 44 partnerships, alliances, and business expansions, four funding activities, and seven mergers and acquisitions activities. Joint ventures, collaborations, and partnerships were among the most frequently followed strategies incorporated by numerous players to establish a strong foothold in the market.

Most of the manufacturers in the market are incorporating collaborations and partnerships with not only other companies but also the university and research institutions as the key strategies to develop novel minimally invasive gastrointestinal surgical systems and attain a strong financial position in the market.

The leading imaging modality providers in the global minimally invasive gastrointestinal surgical systems market include Ambu A/S, B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cook Medical Inc., Intuitive Surgical, Inc., Olympus Corporation, Medtronic plc, Karl Storz SE & Co. KG, Stryker Corporation, Schölly Fiberoptic GmbH, Xenocor Inc., Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Richard Wolf GmbH, and TransEnterix, Inc., among others.

Patient Monitoring Devices Market By Type (Hemodynamic Monitoring, Neuromonitoring, Cardiac Monitoring, Fetal & Neonatal Monitoring, Respiratory Monitoring, Multi-Parameter Monitoring, Remote Patient Monitoring, Weigh Monitoring, And Temperature Monitoring Devices); By End User (Hospitals & Clinics, Home Settings, and Ambulatory Surgical Centers); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030

The post Global Minimally Invasive Gastrointestinal Surgical Systems Market: 12 Countries Analysis – Analysis and Forecast, 2021-2031 first appeared on CRI Report.

Market Segmentation

• Disease Type: Gastroenterology Disease, Endocrine and Metabolism Disorders Disease, Cardiovascular Disorders, Neurology Disease, Hematology and Oncology Disease, Dermatology Disease
• Product Type: Kits and Assays, Panels
• Sample Type: DNA Sample, Buccal Swab Sample, Blood, Saliva
• Technology: Next-Generation Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarrays
• Trait Type: Inherited, Acquired
• Test Type: Genetic Test, General Lab Test, Imaging Test
• Age Group: Children Age, Adult Age
• End User: Hospital Laboratories, Diagnostics Laboratories, Genetic Testing Laboratories, Cancer Research Laboratories, Cancer Research Institutes, Universities Research Laboratories

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, Italy, U.K., Spain, Russia, Rest-of-Europe
• Asia-Pacific – Japan, China, India, Australia, Singapore, Rest-of-APAC
• Latin America – Brazil, Mexico, Rest-of-Latin America
• Rest-of-the-World

Growth Drivers

• Rising Prevalence of Genetic Disorders
• Increasing Research and Development in the Field of Rare Disease Diagnostics
• Rare Genome Projects Leading to Rise in Awareness Regarding Treatment of Disease
• Commitment of Big Pharma and Biotech Companies to Rare Diseases

Market Challenges

• Expensive Sequencing Procedures and Their Applications in Medical Treatments
• High Capital Requirement Hampering the Expansion of Global Reach
• Stringent Regulatory Standards

Market Opportunities

• Technological Advancements in Sample Preparation for Whole Genome and Exome Sequencing in Rare Disease Sequencing
• Huge Opportunity for Pharma and Medical Devices and Biotechnology Companies

Key Companies Profiled

23andMe Inc., 3billion, Inc., Agilent Technologies, Inc., Beijing Genomics Institute (BGI), CENTOGENE N.V., Eurofins Scientific SE, GENEWIZ, Inc., Illumina, Inc., In-Depth Genomics, Invitae Corporation, Laboratory Corporation of America Holdings, OPKO Health, PerkinElmer, Inc., Quest Diagnostics Incorporated, Travere Therapeutics, Inc.

Key Questions Answered in this Report:

• What are the possible long-term and short-term impacts of rare disease testing on the human health continuum?
• What are the major market drivers, challenges, and opportunities in the rare disease testing?
• What are the key development strategies being implemented by the major players in order to sustain in the competitive market?
• What are the key regulatory implications in developed and developing regions for the global rare disease diagnostics market?
• How are service-based companies impacting the growth of the global rare disease testing industry and further shaping up future trends?
• How is each segment of the market expected to grow during the forecast period from 2020 to 2030?
• Who are the leading players with significant offerings to the global rare disease diagnostics market and what is the expected market dominance for each of these leading players?
• Which companies are anticipated to be highly disruptive in the future, and why?
• What are the unmet needs that are yet to be met by the global rare disease diagnostics market with respect to the application areas?
• What are the dynamics of various application areas and countries, which are impacting the global rare disease diagnostics market?
• What are the new market opportunities of various technologies that are influencing the growth of the global rare disease diagnostics market?
• How is each segment of the market is expected to grow during the forecast period from 2020 to 2030? Following are the segment types:
o Product
o Sample
o Technology
o Age group
o Trait
o Test
o End user
o Region

Market Overview

Rare disease diagnostics has grown significantly since the technology was first commercialized with whole genome and exome sequencing, but it is important to quantify that growth and describe future trends. The genome testing industry is proliferating, and its growth is expected to continue at a torrid pace. However, there are significant challenges that may dampen future growth, if not addressed.

Our healthcare experts have found rare disease diagnostics to be one of the most rapidly evolving technologies, and the global market is predicted to grow at a CAGR of 8.57% over the forecast period of 2020-2030.

The unmet clinical needs for better tools to predict, diagnose, treat, and monitor diseases are acting as significant factors driving the growth of the sequencing industry. Other factors fueling the growth include increased understanding of the molecular basis of diseases, patient demand, industry investment, and regulations that allow marketing of tests without the FDA approval.

Despite rapid advanced sequencing industry growth, there are several key issues that need to be addressed to facilitate future growth. The relatively high total costs of delivering sequencing test results compared with other technology platforms, and limited coverage by payers, are the key challenges to the growth of this industry. Whole genome and exome sequencing remain relatively costly, requiring initial equipment investment, specialized workforce requirements, and time-intensive variant interpretation.

Within the research report, the market has been segmented on the basis of disease type, product, sample, age group, testing type, technology, end user, and region. Each of these segments cover the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the application of next-generation sequencing on the global level has created a buzz among companies to invest in the products and services of next-generation sequencing used for rare disease diagnostics. Due to the diverse product portfolio and intense market penetration, whole genome and exome have been pioneers in this field and significant competitors in this market.

Based on region, North America holds the largest share, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. Apart from this, Latin America and the Asia-Pacific are anticipated to grow at the fastest CAGR during the forecast period.

The post Global Rare Disease Diagnostics Market: Focus on Disease, Trait Type, Products, Age Group, Test Type, Technology, End User, Country Data (15 Countries), and Competitive Landscape – Analysis and Forecast, 2020-2030 first appeared on CRI Report.

Market Segmentation

• Product Type – Consumables(Media, Rapid Detection Assays, Reagents and Supplements, Accessories), Equipment and Systems(Filtration Systems, Microbial Detection Systems, Incubators and Culture Systems, Air Monitoring Systems, Sterilization Systems, Others)
• By Application – Pharmaceutical Industry, Food and Beverage Industry, Cosmetic Industry, Water Industry, Biotechnology Industry, Other Industries
• By End User – Biotechnology and Pharmaceutical Companies, Commercial Quality Assurance, Food and Beverage Companies, Research Institutions, Regulatory and Environmental Agencies, Other Industrial End Users

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, U.K., Italy, Spain, and Rest-of-Europe
• Asia-Pacific – China, Japan, India, Australia, and Rest-of-Asia-Pacific (RoAPAC)
• Latin America – Brazil, Mexico, and Rest-of-the-Latin America
• Rest-of-the-World

Growth Drivers

• Growing research and development activity in different industry
• Technological advancements for commercial quality assurance
• Growing demand for safety in food and pharmaceutical industry triggers the market growth

Market Challenges

• Dearth of skilled professional in industrial microbiology laboratories
• High cost of industrial microbiology process

Market Opportunities

• Growing demand for innovative analytic techniques
• Technological advancement in real-time environment monitoring

Key Companies Profiled

3M Company, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Charles River Laboratories International, Inc., Danaher Corporation, Eppendorf AG, HiMedia Laboratories, Hy Laboratories Ltd, Merck KGaA, Novamed, QIAGEN N.V., Sartorius AG, Solenis, Sysmex Corporation, Thermo Fisher Scientific Inc.

Key Questions Answered in this Report:

• What is industrial microbiology?
• How did the industrial microbiology market evolve, and what is its scope in the future?
• What are the major market drivers, restraints, and opportunities in the global industrial microbiology market?
• What are the key developmental strategies that are being implemented by the key players to sustain this market?
• What is the patent landscape of this market? What will be the impact of patent expiry on this market?
• What is the impact of COVID-19 on this market?
• What are the guidelines implemented by different government bodies to regulate the approval of products to be used in industrial microbiology?
• How is industrial microbiology being utilized for the development of therapeutics?
• How will the investments by public and private companies and government organizations affect the global industrial microbiology market?
• What was the market size of the leading segments and sub-segments of the global industrial microbiology market in 2019?
• How will the industry evolve during the forecast period 2020-2030?
• What will be the growth rate of the industrial microbiology market during the forecast period?
• How will each of the segments of the global industrial microbiology market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2030?
• Which product segment and application segment are expected to register the highest CAGR for the global industrial microbiology market?
• What are the major benefits of the implementation of industrial microbiology strategies in different field of applications including pharmaceutical industry, food and beverage industry, cosmetic industry, water industry, biotechnology Industry and other industry?
• What is the market size of the industrial microbiology market in different countries of the world?
• Which geographical region is expected to contribute to the highest sales of industrial microbiology market?
• What are the regulatory and biosafety framework for the industrial microbiology market in different regions?
• What are the key strategies incorporated by the players of global industrial microbiology market to sustain the competition and retain their supremacy?

Market Overview

The capability of genetically engineered cells to make new products revolutionized the processes of industrial microbiology. Techniques like gene mounting and genetic engineering have helped the fermentation industry with enhanced productivity. The use of bioprocesses helped the industries to deliver fine-quality products. The application of industrial microbiology is currently expanding in areas such as therapeutics, diagnostics, environmental protection, mineral recovery, and agriculture, apart from its traditional application in the food and beverage industry.

The global industrial microbiology market was valued to be $5,604.2 million in 2019 and is expected to reach $13,181.2 million by 2030, witnessing a CAGR of 8.36% during the forecast period 2020-2030. The market growth can mainly be attributed to the growing research in the field of industrial microbiology, increasing awareness among researchers about new strains of microorganisms, rise in preference toward consumer products, increase in research and development as well as collaborations in pharmaceutical and biotechnology industries, and use of rapid sterility testing methods for pathogen detection.

The global industrial microbiology market has witnessed high growth in the last decade. The increase in demand for industrial microbiology products can largely be attributed to factors such as increase in the significance of industrial food and safety, growing awareness among researchers about new strains of microorganisms, increasing demand for pathogen testing in food products, growing research initiatives in different fields of industrial microbiology, increasing automation in products, and rising number of collaborations among companies.

Furthermore, the companies are investing huge amount toward innovations of industrial microbiology products. Key strategies followed by the companies include new product launches and mergers and acquisitions for geographical expansion and strengthening of product portfolios. For instance, in February 2019, bioMerieux SA acquired Invisible Sentinel, a U.S.-based company specialized in food and beverage molecular testing, to add the VERIFLOW platform to its industrial microbiology product portfolio. It is an innovative molecular biology solution for the detection of pathogens and spoilage organisms in food and beverages, wine and beer.
Within the research report, the market is segmented based on product type, application, end-user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The global industrial microbiology market is currently dominated by Thermo Fisher Scientific, followed by bioMérieux SA. The market dominance of Thermo Fisher Scientific can be attributed to a large product portfolio for automated microbial detection systems. bioMérieux SA held the second largest market share in the industrial microbiology market, attributed to its significant contribution in the field. The company offers a wide range of products to be utilized for industrial procedures in the biopharmaceutical, food and beverages, and water industry. Merck KGaA holds the third largest share, owing to its diverse range of product offerings in consumables (including media, detection kits, and accessories) and detection systems. Other prominent players, namely, 3M, BD, Bio-Rad Laboratories, Inc., bioMérieux SA, Charles River Laboratories International, Inc., Pall/Danaher Corporation, Merck KGaA, and Eppendorf, collectively hold a large market share of the total global industrial microbiology market in 2019.

Based on region, North America is the leading contributor to the industrial microbiology market in terms of revenue. The fields such as commercial quality assurance and biotechnology & pharmaceutical companies are expected to progress at significant rates, and the substantial investments made in these fields are consequentially promoting the growth of the North America industrial microbiology market. However, the Asia-Pacific and Europe regions, constituting several emerging companies contributing to industrial microbiology, are expected to register the high CAGR during the forecast period of 2020-2030.

The post Global Industrial Microbiology Market: Focus on Products, Applications, End Users, Country Data (13 Countries), and Competitive Landscape – Analysis and Forecast, 2020-2030 first appeared on CRI Report.

Market Segmentation

• Application (Sleep Disorders, Neurophysiology, Brain-Computer Interface, Cognitive Neuroscience, Neuromarketing, and Others)
• End User (Research and Academic Institutes, and Labs, Hospitals, Home Care Settings, and Others)

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, U.K., Italy, Spain, and Rest-of-Europe
• Asia-Pacific – China, Japan, South Korea, India, Australia, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-the-Latin America
• Middle East and Africa

Growth Drivers

• Use of Wireless Brain Sensors for the Diagnosis of Sleep Disorders
• Growing Incidence of Neurological Disorders
• Increasing Applications of Advanced Sensors in Neurological Devices
• Growing Geriatric Population

Market Challenges

• Stringent Regulatory Policies
• Risk of Product Recalls and High Cost of the Devices

Market Opportunities

• Technological Advancements in Wireless Brain Sensors Market
• Regional Expansion and Increasing Adoption of Wireless Brain Sensors in Emerging Economies

Key Companies Profiled

Compumedics Limited, Wearable Sensing, Medtronic Plc, Natus Medical Incorporated, Brain Scientific, Inc, and Nihon Kohden Corporation, EMOTIV, Advanced Brain Monitoring, Inc, Brain Products GmbH, NeuroSky, Neuroelectrics, Cadwell Industries, Inc, Jordan Neuroscience, Inc, BrainScope Company, Inc, and Muse, among others

Key Questions Answered in this Report:

• How has COVID-19 impacted the global wireless brain sensors market?
• What are the key regulations for the development, commercialization, and adoption of wireless brain sensors?
• Which are the leading players that currently hold significant dominance in the global wireless brain sensors market?
• What are the key strategies incorporated by the players of the global wireless brain sensors market to sustain the competition and retain their supremacy?
• What is the patent landscape of the wireless brain sensors market?
• What are the key technological developments on which the current industry leaders are spending their major share of research and development (R&D) investment?
• What is the current market potential of wireless brain sensors, and what factors decide the growth potential of wireless brain sensors for the forecast period?
• What is the current revenue contribution of different products, and how would it evolve in the forecast period?
• Which application contributes to the highest CAGR (%) in the global wireless brain sensors market?
• How does the end-user perception impact the growth of the global wireless brain sensors market?
• Which countries contribute to a major share of the current demand, and which countries hold significant scope for expansion for business activities by players of the global wireless brain sensors market?
• What are the drivers, restraints, and opportunities in the global wireless brain sensors market?

Key USPs of the Report

Following are some of the key contents of the report:

• Funding Scenario
This section encompasses a description of the current funding landscape in the global wireless brain sensors space for key players.

• Regulatory Approved Products
This section includes information on regulatory approved wireless brain sensor products in the market.

• Business Model Analysis
This section comprises information on the key business models deployed in the market by leading players.

• Impact of COVID-19
This section of the report encompasses the following:
o Short-, Mid-, and Long-Term Impact on Wireless Brain Sensors Market
o Regional Impact of COVID-19 Industry
o Entry Barriers and Opportunities for the Companies in Global Wireless Brain Sensors Market

In addition, the report provides:

• A detailed analysis and growth forecast (2021-2030) for different market segments
• Recent developments and trends in the global market landscape
• Factors promoting and inhibiting the market growth
• Case studies to assess the delivery models and strategies adopted by some of the highly funded players in the market

Expert Quote

“In order to gain a competitive share in the wireless brain sensor market, various small-scale and mid-scale companies are collaborating with government organizations and private investors to have significant funding for the development and commercialization of technically advanced wireless brain sensor products across different regions of the world. Ceribell, Inc, BrainScope, and Neural Analytics are some companies which received more than $10 million funding from finance and private investors for their products”.

Scope of the Global Wireless Brain Sensor Market

The purpose of the study is to enable the reader to gain a holistic view of the global wireless brain sensors market by each of the segments mentioned above in the table.

The report constitutes an in-depth analysis of the global wireless brain sensors market, including a thorough analysis of the applications. The study also provides market and business-related information on various applications and end users.

The post Global Wireless Brain Sensors Market: Analysis and Forecast, 2021-30 first appeared on CRI Report.

Market Segmentation

• Product Type – Products (Kits and Assays, Instruments, and Software) and Services
• Sample– Tissue-Based, Blood-Based, Bone Marrow Aspirates, and Others
• Technology – Sequencing (NGS and Traditional Sequencing), Polymerase Chain Reaction (RT-PCR and dPCR), Microarray, and Other Technologies
• Application – Solid Tumors (Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Liver Cancer, Ovarian Cancer, and Other Solid Tumors), and Hematological Malignancies (Leukemia, Lymphoma, and Myeloma)
• End User – Academic and Research Institutions, Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Other End Users

Regional Segmentation

• North America – U.S., and Canada
• Europe – Germany, U.K., France, Italy, Spain, Netherlands, and Rest-of-Europe
• Asia-Pacific – China, Japan, India, Australia, South Korea, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World

Growth Drivers

• Global Increase in Cancer Prevalence
• Increasing Consumer Awareness for Tailored Cancer Therapy
• Decreasing Cost of Sequencing
• Increasing Adoption of Inorganic Growth Strategies in the Market

Market Challenges

• Uncertain Regulatory and Reimbursement Policies
• Lack of Trained Professionals in the Field of Oncology
• Lack of Established Treatment Protocols for High-Valued Cancer Tests in Emerging Economies

Market Opportunities

• Technological Advancements in the Field of Cancer Genomics
• Massive Scope for Adoption of NGS-based Somatic Genetic Testing in the Emerging Markets

Key Companies Profiled

Agilent Technologies, Inc., ARUP Laboratories, ASURAGEN INC., Beijing Genomics Institute (BGI) Genomics Co., Ltd, bioMérieux S.A., CENTOGENE N.V, CIRCULOGENE Theranostics, LLC, F. Hoffmann-La Roche Ltd., Guardant Health, Inc., Illumina, Inc., Invivoscribe, Inc., Laboratory Corporation of America Holdings, Mission Bio, NeoGenomics Laboratories, Inc., OmniSeq, Oxford Nanopore Technologies, Ltd., Pacific Biosciences of California, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, and Thermo Fisher Scientific Inc.

Key Questions Answered in this Report:

• How is somatic genetic testing revolutionizing the field of cancer diagnostics?
• What are the major market drivers, challenges, and opportunities in the global somatic genetic testing market?
• What are the underlying structures resulting in the emerging trends within the global somatic genetic testing market?
• How did the COVID-19 pandemic impact the global somatic genetic testing landscape?
• What are the key development strategies that are being implemented by the major players in order to sustain in the competitive market?
• What are the key regulatory implications in developed and developing regions pertaining to somatic genetic testing?
• What are the potential entry barriers, which are expected to be faced by the companies willing to enter in a particular region?
• How is each segment of the market expected to grow during the forecast period from 2020 to 2030 and what is the anticipated revenue to be generated by each of the segments? Following are the segments:
o Product Type (Products and Services)
o Sample (Tissue-Based, Blood-Based, Bone Marrow Aspirates, and Others)
o Technology (Sequencing, PCR, Microarray, and Others)
o Application (Solid Tumors and Hematological Malignancies)
o End User (Academic and Research Institutions, Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Others)
o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
• What are the growth opportunities for the companies in the region of their operation?
• Who are the leading players with significant offerings in the global somatic genetic testing market?
• Which companies are anticipated to be highly disruptive in the future, and why?
• What are the current unmet needs that are being faced?

Market Overview

Our healthcare experts have found somatic genetic testing industry to be one of the most rapidly evolving and dynamic markets and the global market for somatic genetic testing is predicted to grow at a CAGR of 9.30% over the forecast period of 2020-2030. The market is driven by certain factors, which include, global increase in cancer prevalence, increasing consumer awareness for tailored cancer therapies, decreasing cost of sequencing, and increasing adoption of inorganic growth strategies in the market.

The market is favored by the developments in the field of cancer genomics and its attributes such as somatic mutation analysis. The global somatic genetic testing is witnessing significant growth due to the increase in cancer prevalence, increasing consumer awareness for tailored cancer therapy, decreasing cost of sequencing, and increasing adoption of inorganic growth strategies in the market. Additionally, rapid adoption of sequencing instruments by the researchers to conduct cancer genomic research and increasing emphasis on precision medicine are some of the critical factors, which are expected to bolster the market growth.

Furthermore, biotechnology companies are focusing on the development of robust somatic genetic testing solutions for a wide range of applications to support clinicians for conducting in-depth somatic mutation analysis.

Within the research report, the market is segmented on the basis of product type, sample, technology, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the number of cases associated with cancer has created a buzz among the biotechnology companies, compelling them to further invest in the development of cancer diagnostic solutions for somatic mutation analysis, thereby aiding clinicians to offer precision therapeutics for cancer treatment. Due to the presence of a diverse product portfolio and intense market penetration, Thermo Fisher Scientific Inc. has been a pioneer in this field and has been a significant competitor in this market.

On the basis of region, North America holds the largest share of the somatic genetic testing market due to high infusion of funding from the government organizations for conducting cancer research, growing prevalence of cancer, rising awareness about precision medicine, and increasing awareness about early cancer detection, among others. Apart from this, Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period, 2020-2030.

The post Global Somatic Genetic Testing Market: Focus on Product Type, Sample, Technology, Applications, End Users, Country Data (15 Countries), and Competitive Landscape – Analysis and Forecast, 2020-2030 first appeared on CRI Report.

Key Questions Answered in this Report:

• What are the major drivers, challenges, and opportunities for the global space-based smart sensors and electronics market during the forecast period 2021-2026?
• In which industries (satellite, launch vehicle, and deep space probe) will space-based smart sensors and electronics components have the greatest impact in the near-term?
• What are the recent trends in the space-based smart sensors and electronics segment?
• Which are the key players in the global space-based smart sensors and electronics market, and what is their competitive benchmarking?
• What is the expected revenue generated by the global space-based smart sensors and electronics market during the forecast period 2021-2026?
• What are the strategies adopted by the key players in the market to increase their market presence in the industry?
• Which application (satellite, launch vehicle, and deep space probe) in the space-based smart sensors and electronics market is expected to dominate the market in 2026?
• What was the revenue generated by the global space electronics market (by component) for active component (integrated circuit, microprocessor and microcontroller, active sensors, optoelectronics), passive component (capacitors and supercapacitors, resistors, attenuators, RF passive components, inductors, and transformers), electrical power system, memory, and analog and mixed signal in 2020, and what are the estimates till 2026?
• What was the revenue generated by the global space-based smart sensors and electronics market (by subsystem) – satellite bus and payload in satellites, and avionics and power system in launch vehicles and deep space probes in 2020, and what are the estimates till 2026?
• What was the revenue generated by the global space electronics market (by product) (radiation-hardened and radiation-tolerant) in 2020, and what are the estimates till 2026?
• What are the competitive strengths of the key players in the space-based smart sensors and electronics market?
• What would be the aggravated revenue generated by the space-based smart sensors and electronics market segmented by region (North America, Europe, Asia-Pacific, and Rest-of-the-World) till 2026?

Global Space-Based Smart Sensors and Electronics Market Forecast, 2021-2026

The space-based smart sensors and electronics industry analysis by BIS Research projects the market to have significant growth of CAGR 4.85% during the forecast period 2021-2026. North America is expected to dominate the global space-based smart sensors and electronics market with an estimated share of 44.72% in 2026.

North America, including the major countries such as the U.S., is the most prominent region for the space-based smart sensors and electronics market. The presence of major players and intense competition among them makes North America the most technologically advanced region.

The global space-based smart sensors and electronics market is gaining widespread importance owing to the rising demand for small satellites, and the increasing reliability and functionality of launch vehicles and deep space probes. Moreover, the increased utilization of the commercial-of-the-shelf (COTS) component is one of the key factors that may propel the market growth in the coming years.

Scope of the Global Space-Based Smart Sensors and Electronics Market

The purpose of the market analysis is to examine the space-based smart sensors and electronics market outlook in terms of factors driving the market, trends, technological developments, and competitive benchmarking, among others.

The report further takes into consideration the market dynamics and the competitive landscape of the key players operating in the market.

Global Space-Based Smart Sensors and Electronics Market Segmentation

The report constitutes an extensive study of the space-based smart sensors and electronics industry. The report largely focuses on providing market information for space-based smart sensors and electronics covering various segments and regions. The space-based smart sensors and electronics market is segmented on the basis of product type, application, subsystem, component, application, and region.

While highlighting the key driving and restraining forces for this market, the report also provides a detailed study of the industry. The report analyzes different applications that include satellite, launch vehicle, and deep space probe. The product type segment is segmented into radiation-hardened and radiation-tolerant.

Also, the sub-system segment is segmented into satellite (payload, satellite bus), launch vehicle (avionics, power system) and deep space probe (avionics, power system).

On the basis of component, the market is segmented into active component (integrated circuit, microprocessor and microcontroller, active sensors, optoelectronics), passive component (capacitors and supercapacitors, resistors, attenuators, RF passive components, inductors, and transformers), electrical power system, memory, and analog and mixed signal.

The space-based smart sensors and electronics market is segregated into four major regions, namely North America, Europe, Asia-Pacific, and Rest-of-the-World. Data for each of these regions, along with country-level analyses, is provided in the market study.

Key Companies in the Global Space-based Smart Sensors and Electronics Industry

The key market players in the global space-based smart sensors and electronics market include Analog Device Inc, BAE Systems, Cobham plc, Data Device Corporation, Exxelia, Honeywell International, Infineon Technologies, Microchip, Micropac, Teledyne Technologies, Texas Instruments Inc., The Boeing Company, Xilinx Inc., STMicroelectronics N.V, TT Electronics, and Solid-State Devices Inc.

Global Aerospace Lubricant Market Analysis and Forecast Report 2030

The post Space-based Smart Sensors and Electronics Market – A Global and Regional Analysis: Focus on Product Type, Subsystem, Component, and Application – Analysis and Forecast, 2021-2026 first appeared on CRI Report.